Post Archive by Year

Findings seen during 18+ years of follow-up and persist when accounting for sociodemographic factors

Significant reduction seen in primary end point of composite incidence of ischemic stroke, transient ischemic attack, death within 30 days

Tirzepatide and semaglutide offer long-term health benefits, but would require discounts to reach $100,000/QALY threshold

Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality

Mothers with a newborn with congenital heart disease also have increased risk of cancer

Doubling of vitamin B12 associated with lower systolic and diastolic blood pressure

Odds of all CVD conditions significantly higher in bottom 80 percent income groups versus top 20 percent income groups

9.1 percent were reported after 180 days; small number of manufacturers submitted most of the late reports

Combination of insomnia and short sleep increases risk for hypertension fivefold

Medium and high T2DM genetic risk not linked to increased risk for ASCVD when TV viewing is no more than one hour/day